Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With Dyslipidemia

A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With Dyslipidemia

A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients with Dyslipidemia

To evaluate the efficacy and safety of JW0108+C2407 in dyslipidemia patients

Inclusion Criteria:

• Age of 19 years old at the time of written informed consent
• Patients with dyslipidemia

Exclusion Criteria:

• Secondary dyslipidemia
• Patient who does not meet the specified TG, LDL-C level